TY - JOUR
T1 - MiR-766 induces p53 accumulation and G2/M arrest by directly targeting MDM4
AU - Wang, Qingqing
AU - Selth, Luke A.
AU - Callen, David F.
PY - 2017/1/1
Y1 - 2017/1/1
N2 - P53, a transcription factor that participates in multiple cellular functions, is considered the most important tumor suppressor. Previous evidence suggests that post-transcriptional deregulation of p53 by microRNAs contributes to tumorigenesis, tumor progression and therapeutic resistance. In the present study, we found that the microRNA miR-766 was aberrantly expressed in breast cancer, and that overexpression of miR-766 caused accumulation of wild-type p53 protein in multiple cancer cell lines. Supporting its role in the p53 signalling pathway, miR-766 decreased cell proliferation and colony formation in several cancer cell lines, and cell cycle analyses revealed that miR-766 causes G2 arrest. At a mechanistic level, we demonstrate that miR-766 enhances p53 signalling by directly targeting MDM4, an oncogene and negative regulator of p53. Analysis of clinical genomic data from multiple cancer types supports the relevance of miR-766 in p53 signalling. Collectively, our study demonstrates that miR-766 can function as a novel tumor suppressor by enhancing p53 signalling.
AB - P53, a transcription factor that participates in multiple cellular functions, is considered the most important tumor suppressor. Previous evidence suggests that post-transcriptional deregulation of p53 by microRNAs contributes to tumorigenesis, tumor progression and therapeutic resistance. In the present study, we found that the microRNA miR-766 was aberrantly expressed in breast cancer, and that overexpression of miR-766 caused accumulation of wild-type p53 protein in multiple cancer cell lines. Supporting its role in the p53 signalling pathway, miR-766 decreased cell proliferation and colony formation in several cancer cell lines, and cell cycle analyses revealed that miR-766 causes G2 arrest. At a mechanistic level, we demonstrate that miR-766 enhances p53 signalling by directly targeting MDM4, an oncogene and negative regulator of p53. Analysis of clinical genomic data from multiple cancer types supports the relevance of miR-766 in p53 signalling. Collectively, our study demonstrates that miR-766 can function as a novel tumor suppressor by enhancing p53 signalling.
KW - Cancer
KW - Cell cycle
KW - MDM4
KW - MicroRNA
KW - P53
UR - http://www.scopus.com/inward/record.url?scp=85018941801&partnerID=8YFLogxK
UR - http://purl.org/au-research/grants/NHMRC/1048134
UR - http://purl.org/au-research/grants/NHMRC/1083961
U2 - 10.18632/oncotarget.15530
DO - 10.18632/oncotarget.15530
M3 - Article
AN - SCOPUS:85018941801
SN - 1949-2553
VL - 8
SP - 29914
EP - 29924
JO - Oncotarget
JF - Oncotarget
IS - 18
ER -